DNMT1 and colorectal carcinoma: In conclusion, the study stresses that suppressed DNMT1 leads to non‐methylated miR‐152‐3p to depress TMSB10 expression, thereby inhibiting the proliferation and metastasis and promoting the apoptosis of CRC cells, which offers a new avenue for CRC therapy.